scholarly journals Antiviral Activity of a Turbot (Scophthalmus maximus) NK-Lysin Peptide by Inhibition of Low-pH Virus-Induced Membrane Fusion

Marine Drugs ◽  
2019 ◽  
Vol 17 (2) ◽  
pp. 87 ◽  
Author(s):  
Alberto Falco ◽  
Regla Medina-Gali ◽  
José Poveda ◽  
Melissa Bello-Perez ◽  
Beatriz Novoa ◽  
...  
Keyword(s):  
Antiviral Activity ◽  
Viral Infections ◽  
Scophthalmus Maximus ◽  
Low Ph ◽  
Host Cells ◽  
Viral Origin ◽  
Membrane Rupture ◽  
Viral Particles ◽  
Strong Antiviral Activity ◽  
Turbot Scophthalmus Maximus

Global health is under attack by increasingly-frequent pandemics of viral origin. Antimicrobial peptides are a valuable tool to combat pathogenic microorganisms. Previous studies from our group have shown that the membrane-lytic region of turbot (Scophthalmus maximus) NK-lysine short peptide (Nkl71–100) exerts an anti-protozoal activity, probably due to membrane rupture. In addition, NK-lysine protein is highly expressed in zebrafish in response to viral infections. In this work several biophysical methods, such as vesicle aggregation, leakage and fluorescence anisotropy, are employed to investigate the interaction of Nkl71–100 with different glycerophospholipid vesicles. At acidic pH, Nkl71–100 preferably interacts with phosphatidylserine (PS), disrupts PS membranes, and allows the content leakage from vesicles. Furthermore, Nkl71–100 exerts strong antiviral activity against spring viremia of carp virus (SVCV) by inhibiting not only the binding of viral particles to host cells, but also the fusion of virus and cell membranes, which requires a low pH context. Such antiviral activity seems to be related to the important role that PS plays in these steps of the replication cycle of SVCV, a feature that is shared by other families of virus-comprising members with health and veterinary relevance. Consequently, Nkl71–100 is shown as a promising broad-spectrum antiviral candidate.

scholarly journals Targeting Viral Surface Proteins through Structure-Based Design

Viruses ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1320
Author(s):  
Yogesh B Narkhede ◽  
Karen J Gonzalez ◽  
Eva-Maria Strauch
Keyword(s):  
Public Health ◽  
Viral Infections ◽  
Respiratory Viruses ◽  
Surface Proteins ◽  
Host Cells ◽  
Viral Fusion ◽  
Health It ◽  
Viral Particles ◽  
Pathogenic Viruses ◽  
Viral Surface

The emergence of novel viral infections of zoonotic origin and mutations of existing human pathogenic viruses represent a serious concern for public health. It warrants the establishment of better interventions and protective therapies to combat the virus and prevent its spread. Surface glycoproteins catalyzing the fusion of viral particles and host cells have proven to be an excellent target for antivirals as well as vaccines. This review focuses on recent advances for computational structure-based design of antivirals and vaccines targeting viral fusion machinery to control seasonal and emerging respiratory viruses.

scholarly journals Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract

Viruses ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 1111 ◽  
Author(s):  
Mayra A. Meléndez-Villanueva ◽  
Karla Morán-Santibañez ◽  
Juan J. Martínez-Sanmiguel ◽  
Raúl Rangel-López ◽  
Marco A. Garza-Navarro ◽  
...  
Keyword(s):  
Gold Nanoparticles ◽  
Antiviral Activity ◽  
Measles Virus ◽  
Viral Infections ◽  
Vero Cells ◽  
Garlic Extract ◽  
World Health ◽  
Viral Particles ◽  
Virucidal Effect ◽  
Health Organization

Measles virus (MeV) is a paramyxovirus that infects humans, principally children. Despite the existence of an effective and safe vaccine, the number of cases of measles has increased due to lack of vaccination coverage. The World Health Organization (WHO) reports that the number of cases worldwide multiplied fourfold between January and March 2019, to 112,000. Today, there is no treatment available for MeV. In recent years, it has been demonstrated that natural extracts (herbal or algal) with antiviral activity can also work as reducing agents that, in combination with nanotechnology, offer an innovative option to counteract viral infections. Here, we synthetized and evaluated the antiviral activity of gold nanoparticles using garlic extract (Allium sativa) as a reducing agent (AuNPs-As). These nanoparticles actively inhibited MeV replication in Vero cells at a 50% effective concentration (EC50) of 8.829 µg/mL, and the selectivity index (SI) obtained was 16.05. AuNPs-As likely inhibit viral infection by blocking viral particles directly, showing a potent virucidal effect. Gold nanoparticles may be useful as a promising strategy for treating and controlling the infection of MeV and other related enveloped viruses.

scholarly journals Mathematical Modeling of Autoimmune Diseases

Symmetry ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 1457
Author(s):  
Mikhail Kolev
Keyword(s):  
Immune System ◽  
Autoimmune Diseases ◽  
Viral Infections ◽  
Nonequilibrium Statistical Mechanics ◽  
Good Health ◽  
The Body ◽  
Host Cells ◽  
Human Organism ◽  
Viral Particles ◽  
Harmful Effects

The human organism is a very complex system. To be in good health, its components must function properly. One of the most important systems of an organism is the immune system. It protects the body from the harmful effects of various external and internal agents. Sometimes, however, the immune system starts attacking its own healthy cells, tissues and organs. Then autoimmune diseases arise. They are widespread in recent decades. There is evidence that often autoimmune responses occur due to viral infections. In this paper, a new mathematical model of a general autoimmune disease is proposed. It describes the interactions between viral particles and host cells. The model is formulated by using integro-differential equations of Boltzmann type. This approach is typical for the nonequilibrium statistical mechanics. A preliminary qualitative and quantitative analysis of the model is presented.

scholarly journals Stably Expressed APOBEC3F Has Negligible Antiviral Activity

2010 ◽  
Vol 84 (21) ◽  
pp. 11067-11075 ◽  
Author(s):  
Eri Miyagi ◽  
Charles R. Brown ◽  
Sandrine Opi ◽  
Mohammad Khan ◽  
Ritu Goila-Gaur ◽  
...  
Keyword(s):  
Antiviral Activity ◽  
Cytidine Deaminase ◽  
Wild Type ◽  
Cytidine Deaminases ◽  
Protein Levels ◽  
Expression Studies ◽  
Viral Particles ◽  
Hela Cell Lines ◽  
Strong Antiviral Activity ◽  
Exogenous Expression

ABSTRACT APOBEC3F (A3F) is a member of the family of cytidine deaminases that is often coexpressed with APOBEC3G (A3G) in cells susceptible to HIV infection. A3F has been shown to have strong antiviral activity in transient-expression studies, and together with A3G, it is considered the most potent cytidine deaminase targeting HIV. Previous analyses suggested that the antiviral properties of A3F can be dissociated from its catalytic deaminase activity. We were able to confirm the deaminase-independent antiviral activity of exogenously expressed A3F; however, we also noted that exogenous expression was associated with very high A3F mRNA and protein levels. In analogy to our previous study of A3G, we produced stable HeLa cell lines constitutively expressing wild-type or deaminase-defective A3F at levels that were more in line with the levels of endogenous A3F in H9 cells. A3F expressed in stable HeLa cells was packaged into Vif-deficient viral particles with an efficiency similar to that of A3G and was properly targeted to the viral nucleoprotein complex. Surprisingly, however, neither wild-type nor deaminase-defective A3F inhibited HIV-1 infectivity. These results imply that the antiviral activity of endogenous A3F is negligible compared to that of A3G.

scholarly journals Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation

2020 ◽  
Vol 9 (4) ◽  
pp. 959
Author(s):  
Isaac Hurtado-Guerrero ◽  
Bruno Hernáez ◽  
María J. Pinto-Medel ◽  
Esther Calonge ◽  
José L. Rodriguez-Bada ◽  
...  
Keyword(s):  
Antiviral Activity ◽  
Viral Infections ◽  
Biological Activities ◽  
Cell Monolayer ◽  
Soluble Receptors ◽  
Immune Mediated ◽  
Agonist And Antagonist ◽  
Antiviral Activities ◽  
Strong Antiviral Activity ◽  
Promising Treatment

Soluble receptors of cytokines are able to modify cytokine activities and therefore the immune system, and some have intrinsic biological activities without mediation from their cytokines. The soluble interferon beta (IFN-ß) receptor is generated through alternative splicing of IFNAR2 and has both agonist and antagonist properties for IFN-ß, but its role is unknown. We previously demonstrated that a recombinant human soluble IFN-ß receptor showed intrinsic therapeutic efficacy in a mouse model of multiple sclerosis. Here we evaluate the potential biological activities of recombinant sIFNAR2 without the mediation of IFN-ß in human cells. Recombinant sIFNAR2 down-regulated the production of IL-17 and IFN-ɣ and reduced the cell proliferation rate. Moreover, it showed a strong antiviral activity, fully protecting the cell monolayer after being infected by the virus. Specific inhibitors completely abrogated the antiviral activity of IFN-ß, but not that of the recombinant sIFNAR2, and there was no activation of the JAK-STAT signaling pathway. Consequently, r-sIFNAR2 exerts immunomodulatory, antiproliferative and antiviral activities without IFN-ß mediation, and could be a promising treatment against viral infections and immune-mediated diseases.

scholarly journals Antiviral Activity of PD-L1 and PD-L4, Type 1 Ribosome Inactivating Proteins from Leaves of Phytolacca dioica L. in the Pathosystem Phaseolus vulgaris–Tobacco Necrosis Virus (TNV)

Toxins ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 524
Author(s):  
Daniela Bulgari ◽  
Nicola Landi ◽  
Sara Ragucci ◽  
Franco Faoro ◽  
Antimo Di Maro
Keyword(s):  
Cell Death ◽  
Phaseolus Vulgaris ◽  
Antiviral Activity ◽  
Early Stage ◽  
Host Cells ◽  
Tobacco Necrosis Virus ◽  
Necrosis Virus ◽  
Ribosome Inactivating Proteins ◽  
Strong Antiviral Activity

Using the pathosystem Phaseolus vulgaris–tobacco necrosis virus (TNV), we demonstrated that PD-L1 and PD-L4, type-1 ribosome inactivating proteins (RIPs) from leaves of Phytolacca dioica L., possess a strong antiviral activity. This activity was exerted both when the RIPs and the virus were inoculated together in the same leaf and when they were inoculated or applied separately in the adaxial and abaxial leaf surfaces. This suggests that virus inhibition would mainly occur inside plant cells at the onset of infection. Histochemical studies showed that both PD-L1 and PD-L4 were not able to induce oxidative burst and cell death in treated leaves, which were instead elicited by inoculation of the virus alone. Furthermore, when RIPs and TNV were inoculated together, no sign of H2O2 deposits and cell death were detectable, indicating that the virus could have been inactivated in a very early stage of infection, before the elicitation of a hypersensitivity reaction. In conclusion, the strong antiviral activity is likely exerted inside host cells as soon the virus disassembles to start translation of the viral genome. This activity is likely directed towards both viral and ribosomal RNA, explaining the almost complete abolition of infection when virus and RIP enter together into the cells.

scholarly journals Aptamers for Anti-Viral Therapeutics and Diagnostics

2021 ◽  
Vol 22 (8) ◽  
pp. 4168
Author(s):  
Tae-Hyeong Kim ◽  
Seong-Wook Lee
Keyword(s):  
Viral Infections ◽  
Modern Medicine ◽  
Host Cells ◽  
Form Of Life ◽  
Appropriate Treatment ◽  
Viral Particles ◽  
Infected Cells ◽  
Viral Diagnosis ◽  
Exponential Enrichment ◽  
Therapeutic Perspective

Viral infections cause a host of fatal diseases and seriously affect every form of life from bacteria to humans. Although most viral infections can receive appropriate treatment thereby limiting damage to life and livelihood with modern medicine and early diagnosis, new types of viral infections are continuously emerging that need to be properly and timely treated. As time is the most important factor in the progress of many deadly viral diseases, early detection becomes of paramount importance for effective treatment. Aptamers are small oligonucleotide molecules made by the systematic evolution of ligands by exponential enrichment (SELEX). Aptamers are characterized by being able to specifically bind to a target, much like antibodies. However, unlike antibodies, aptamers are easily synthesized, modified, and are able to target a wider range of substances, including proteins and carbohydrates. With these advantages in mind, many studies on aptamer-based viral diagnosis and treatments are currently in progress. The use of aptamers for viral diagnosis requires a system that recognizes the binding of viral molecules to aptamers in samples of blood, serum, plasma, or in virus-infected cells. From a therapeutic perspective, aptamers target viral particles or host cell receptors to prevent the interaction between the virus and host cells or target intracellular viral proteins to interrupt the life cycle of the virus within infected cells. In this paper, we review recent attempts to use aptamers for the diagnosis and treatment of various viral infections.

scholarly journals Decreased rotavirus infection of MA104 cells via probiotic extract binding to Hsc70 and ß3 integrin receptors

2018 ◽  
Vol 23 (2) ◽  
pp. 219-239 ◽  
Author(s):  
Sandra Patricia Salas-Cárdenas ◽  
Nury Natalia Olaya-Galán ◽  
Karem Fernández ◽  
Fernando Velez ◽  
Carlos Arturo Guerrero ◽  
...  
Keyword(s):  
Antiviral Activity ◽  
Viral Infections ◽  
Antiviral Effect ◽  
Host Cells ◽  
Probiotic Bacteria ◽  
Bacterial Strains ◽  
Ma104 Cell ◽  
Cell Receptors ◽  
Surface Receptors ◽  
Protein Rich

Probiotic bacteria are microorganisms beneficial to human health, useful to improving biological conditions. Thanks to probiotic bacteria the symptoms of viral infections can be alleviated. Different mechanisms whereby probiotic bacteria exert they antiviral effect have been proposed. The aim of this study was to determine whether probiotic bacteria extracts bind to receptors of host cells susceptible of rotavirus (RV) infection. To accomplish this objective, four probiotic bacterial strains of Lactobacillus spp. and Bifidobacterium spp. were tested. Probiotic extracts were obtained after bacterial growth, cell lysis and centrifugation. Obtained probiotic extracts were used in assays to interfere with adhesion and penetration of a RV strain in the mammal cell line MA104. Furthermore, the interaction between probiotic extracts and MA104 cell receptors was evaluated by co-immunoprecipitation assays using anti-ß3-integrins and anti-Hsc70 antibodies. All four probiotic, protein-rich, extracts reduced RV infections in MA104 cells, suggesting a successful antiviral activity mediated by these probiotic extracts. All probiotic extracts significantly exerted thir antiviral activity by interfering with RV adhesion on MA104 cell receptors, with proteins in probiotic extracts competitively interacting with cell surface receptors necessary to RV infection. Co-immunoprecipitation assay results showed that proteins in probiotic extracts were able to bind to ß3-integrinsand Hsc70, which are two cellular receptors required to viral infection. The most significant contribution of this study is an insight into the mechanisms of probiotic antiviral activity, thus expanding current probiotics fundamental knowledge.

scholarly journals Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses

Viruses ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 35
Author(s):  
Bimalendu Ray ◽  
Imran Ali ◽  
Subrata Jana ◽  
Shuvam Mukherjee ◽  
Saikat Pal ◽  
...  
Keyword(s):  
Antiviral Activity ◽  
Viral Infection ◽  
Molecular Mechanisms ◽  
Viral Infections ◽  
Structural Characteristics ◽  
Antiviral Agents ◽  
Host Cells ◽  
Sulfated Polysaccharides ◽  
Susceptible Host ◽  
Pathogenic Viruses

Only a mere fraction of the huge variety of human pathogenic viruses can be targeted by the currently available spectrum of antiviral drugs. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has highlighted the urgent need for molecules that can be deployed quickly to treat novel, developing or re-emerging viral infections. Sulfated polysaccharides are found on the surfaces of both the susceptible host cells and the majority of human viruses, and thus can play an important role during viral infection. Such polysaccharides widely occurring in natural sources, specifically those converted into sulfated varieties, have already proved to possess a high level and sometimes also broad-spectrum antiviral activity. This antiviral potency can be determined through multifold molecular pathways, which in many cases have low profiles of cytotoxicity. Consequently, several new polysaccharide-derived drugs are currently being investigated in clinical settings. We reviewed the present status of research on sulfated polysaccharide-based antiviral agents, their structural characteristics, structure–activity relationships, and the potential of clinical application. Furthermore, the molecular mechanisms of sulfated polysaccharides involved in viral infection or in antiviral activity, respectively, are discussed, together with a focus on the emerging methodology contributing to polysaccharide-based drug development.

Sign in / Sign up

Export Citation Format

Share Document